|
Pathway | Count (gene no.) | Enrichment value | Target genes |
|
Regulation of actin cytoskeleton | 14 | | VAV2;IQGAP2;RRAS2;ITGB1;PAK7;SOS1;DOCK1;PPP1CB;SSH2;BAIAP2;ABI2;APC;ITGB3;SSH1 |
MAPK signaling pathway | 14 | | DUSP4;PRKCB;RPS6KA3;RRAS2;BDNF;MAP3K2;SOS1;ELK4;TRAF6;STK4;CACNB4;MAP3K13;FOS;PRKCA |
Ubiquitin mediated proteolysis | 13 | | UBE2E3;CDC27;RCHY1;UBA2;FBXW7;HERC3;UBR5;UBE2D1;TRAF6;HERC4;UBE2B;VHL;MID1 |
Focal adhesion | 12 | | VAV2;PRKCB;COL1A1;VASP;ITGB1;PAK7;SOS1;DOCK1;PPP1CB;PTEN;ITGB3;PRKCA |
Melanogenesis | 11 | | CREBBP;PRKCB;FZD3;FZD9;CALM2;KITLG;WNT5A;CREB1;CALM1;FZD7;\linebreak PRKCA |
Phosphatidylinositol signaling system | 10 | | PRKCB;CDS2;CALM2;ITPKB;DGKB;PTEN;CDS1;INPP5E;CALM1;PRKCA |
Tight junction | 10 | | LLGL2;PRKCB;RRAS2;PPP2R2B;VAPA;PARD6B;PTEN;TJP1;PPP2R2A;PRKCA |
Wnt signaling pathway | 10 | | NFAT5;CREBBP;PRKCB;TBL1X;FZD3;FZD9;WNT5A;FZD7;APC;PRKCA |
Calcium signaling pathway | 10 | | ERBB3;PRKCB;TRPC1;CALM2;ITPKB;ATP2B4;ERBB4;CALM1;SLC8A1;PRKCA |
Cell cycle | 9 | | CCNA2;CREBBP;YWHAZ;CDC27;YWHAE;CDK6;CCNB1;CHEK2;MCM6 |
Axon guidance | 9 | | EPHA3;NFAT5;EPHB1;EFNB2;ITGB1;PAK7;DCC;SEMA6D;ABLIM3 |
Insulin signaling pathway | 9 | | PCK1;IRS2;CALM2;SOS1;PPARGC1A;PPP1CB;RHOQ;PRKAR2B;CALM1 |
p53 signaling pathway | 8 | | CCNG2;RCHY1;CDK6;PPM1D;PTEN;CCNB1;CHEK2;APAF1 |
Long-term potentiation | 8 | | CREBBP;PRKCB;RPS6KA3;CALM2;PPP1CB;CALM1;GRIA1;PRKCA |
Colorectal cancer | 8 | | APPL1;FZD3;FZD9;SOS1;DCC;FZD7;APC;FOS |
Glioma | 7 | | PRKCB;CALM2;SOS1;CDK6;PTEN;CALM1;PRKCA |
ErbB signaling pathway | 7 | | ERBB3;EREG;PRKCB;PAK7;SOS1;ERBB4;PRKCA |
Glycosphingolipid biosynthesis-lactoseries | 6 | | B4GALT4;B3GALT2;B4GALT1;FUT9;ST8SIA1;GCNT2 |
Nonsmall cell lung cancer | 6 | | RASSF5;PRKCB;SOS1;CDK6;STK4;PRKCA |
B cell receptor signaling pathway | 6 | | VAV2;NFAT5;PRKCB;SOS1;DAPP1;FOS |
Adherens junction | 6 | | CREBBP;LMO7;SSX2IP;TJP1;BAIAP2;PTPRB |
TGF-beta signaling pathway | 6 | | ACVR2B;BMPR1A;CREBBP;SMAD7;BMPR2;BMPR1B |
GnRH signaling pathway | 6 | 0.001 | PRKCB;MAP3K2;CALM2;SOS1;CALM1;PRKCA |
Leukocyte transendothelial migration | 6 | 0.002 | RASSF5;VAV2;PRKCB;VASP;ITGB1;PRKCA |
Natural killer cell mediated cytotoxicity | 6 | 0.005 | VAV2;NFAT5;PRKCB;SOS1;SH2D1A;SH2D1A;PRKCA |
Cytokine-cytokine receptor interaction | 6 | 0.076 | ACVR2B;BMPR1A;TNFSF13B;KITLG;BMPR2;BMPR1B |
Basal cell carcinoma | 5 | | FZD3;FZD9;WNT5A;FZD7;APC |
Cholera-infection | 5 | | PRKCB;TJP1;ATP6V0A2;KDELR2;PRKCA |
Adipocytokine signaling pathway | 5 | | ACSL6;PCK1;IRS2;PPARGC1A;ACSL5 |
PPAR signaling pathway | 5 | 0.001 | ACSL6;PCK1;FABP3;ME1;ACSL5 |
ECM-receptor interaction | 5 | 0.003 | CD47;COL1A1;DAG1;ITGB1;ITGB3 |
Gap junction | 5 | 0.004 | PRKCB;MAP3K2;SOS1;TJP1;PRKCA |
T cell receptor signaling pathway | 5 | 0.008 | VAV2;NFAT5;PAK7;SOS1;FOS |
Renal cell carcinoma | 5 | 0.001 | CREBBP;EPAS1;PAK7;SOS1;EPAS1;VHL |
Small cell lung cancer | 5 | 0.003 | ITGB1;CDK6;TRAF6;PTEN;APAF1 |
Alzheimerโs disease | 5 | 0.049 | CALM2;UQCRB;CALM1;APAF1;NDUFA4 |
|